Moore MC, Menon R, Coate KC, Gannon M, Smith MS, Farmer B, Williams PE. Diet-induced impaired glucose tolerance and gestational diabetes in the dog. J Appl Physiol 110: 458 -467, 2011. First published November 18, 2010 doi:10.1152/japplphysiol.00768.2010.-Glucose metabolism was compared in dogs consuming a chow/meat diet throughout pregnancy (P group, n ϭ 6) and dogs switched to a high-fat/high-fructose (HFF) diet during the 4th-5th gestational week (gestation Ӎ9 wk; P-HFF group; n ϭ 6). An oral glucose tolerance test (OGTT; 0.9 g/kg) was administered in the 6th-7th gestational week, and a hyperinsulinemic [0 -120 min: 1.8 pmol·kg Ϫ1 ·min Ϫ1 (low insulin); 120 -240 min: 9 pmol·kg Ϫ1 ·min Ϫ1 (high insulin)] euglycemic clamp was performed the following week. Nonpregnant (NP) female dogs underwent OGTTs but not clamp studies. All P-HFF dogs exhibited impaired glucose tolerance (IGT) or gestational diabetes (GDM), but only one P dog had IGT. Insulin concentrations in P and P-HFF dogs were significantly lower than in NP dogs 30 and 60 min after the OGTT. Therefore, mean islet size and area were evaluated in P and NP dogs. These values did not differ between groups, and proliferating endocrine cells were rare in pregnancy. During exposure to high insulin, glucose infusion rate and hindlimb glucose uptake were ϳ30% greater (P Ͻ 0.05) and net hepatic glucose output was more suppressed (Ϫ5.5 Ϯ 6.1 vs. 7.8 Ϯ 2.8 mg·100 g liver Ϫ1 ·min Ϫ1 , P Ͻ 0.05) in P than in P-HFF dogs. In conclusion, in the 2nd trimester the canine pancreas does not exhibit islet hypertrophy, hyperplasia, or neogenesis. Combined with the lack of pancreatic adaptation, a HFF diet during late pregnancy produces a canine model of IGT and GDM without hyperinsulinemia but exhibiting liver and muscle insulin resistance.
GESTATIONAL DIABETES (GDM), or diabetes manifested during pregnancy, affects 2-10% of pregnancies in the U.S. (15) . Women with GDM are seven times more likely to develop type 2 diabetes at some point in life than women who do not have GDM (4) . Metabolic risk is not limited to women with overt diabetes; instead, the impact of altered glucose tolerance lies on a continuum such that impaired glucose tolerance (IGT) during pregnancy is also associated with an increased risk of metabolic syndrome, cardiovascular disease, prediabetes, and diabetes after pregnancy (44 -47) .
Animal models of IGT in pregnancy and GDM are needed to examine the pathophysiology associated with the human disorders. There are several small animal models of diabetes in pregnancy. These include the streptozotocin-treated mouse or rat. This model is poorly suited for the study of GDM, because large doses of streptozotocin create a model more closely resembling type 1 diabetes, whereas smaller doses result in varying levels of hyperglycemia and lack of fetal macrosomia (9) . In addition, these models are associated with high rates of reproductive failure (infertility and resorption of fetuses) (31, 57) .
Human GDM has a strong genetic and familial component, being more prevalent in particular minority ethnic groups; common variants in several genes (KCNJ11, GCK, and HNF4a) increase the risk of GDM (48) . Likewise, several genetic models of IGT and GDM have been developed in mice. Most recently, our group has demonstrated, using conditional gene inactivation (58) , that the FoxM1 transcription factor is critical for ␤-cell proliferation and ␤-cell mass expansion during pregnancy in mice. This model is similar to human GDM in that a phenotype is manifested specifically at midgestation, whereas virgin and postpartum mutant females show no phenotype. Human GDM patients likely have an underlying undetected ␤-cell defect that becomes apparent only under the physiological stress of pregnancy.
In addition to pharmacological and genetic models, rats and mice fed a high-fat diet have been shown to be hyperinsulinemic and hyperglycemic during pregnancy and to provide a useful model of GDM (28, 34) . Despite the advances in establishing rodent models of the disease, a suitable large animal model would allow more extensive study of metabolism in GDM, including interorgan balance measurements, and would permit the assessment of pharmacological interventions on maternal hepatic and whole body glucose metabolism.
The chronically catheterized dog model has a near-unique advantage in the study of nutrient metabolism, because it is one of the very few models in which it is possible to assess hepatic substrate uptake directly. Hepatic glucose uptake (HGU) is a key variable, because it helps to determine postprandial glycemia. Glucose intolerance in pregnancy not only predicts a number of complications during pregnancy but also is a predictor of future metabolic dysfunction in both the mother and child (e.g., Refs. 27, 45, 46) . Thus an appropriate canine model can provide a basis for further studies defining the pathology of IGT/GDM when the liver is in uptake mode and for examining interventions aimed at alleviating the pathology. The dog is well suited to this purpose and has been used extensively as a model of glucose metabolism in health and disease (e.g., Refs. 10, 21) . This project was undertaken to compare glucose tolerance and hepatic and peripheral insulin sensitivity in pregnant dogs (3rd trimester) receiving a normal chow and meat diet and those fed a high-fat and high-fructose diet. In view of the fact that even normal pregnant dogs exhibited little rise in plasma insulin following ingestion of an oral glucose load compared with normal nonpregnant animals, islet size and proliferation were assessed late in the 2nd trimester to examine the potential for ␤-cell adaptation in pregnancy.
MATERIALS AND METHODS

Animals, Animal Care, and Surgical Procedures
The protocol was approved by the Vanderbilt University Animal Care and Use Committee, and the animals were housed in an American Association for the Accreditation of Laboratory Animal Careapproved facility. Healthy adult timed-pregnant purpose-bred female mongrel dogs were studied. Initially, all dogs consumed the same diet, consisting of laboratory chow and meat (PMI Nutrition canine diet 5006, St. Louis, MO, and Kal Kan, Vernon, CA; metabolizable energy: 31% protein, 26% fat, and 42% carbohydrate, ϳ1,650 -1,850 kcal/day). The carbohydrate in the chow and meat diet was virtually all in the form of starch. In the 4th to 5th week of gestation (term ϳ9 wk), 6 dogs (P-HFF group) were randomly assigned to a high-fat/ high-sugar diet composed of 22% protein, 52% fat, and 26% carbohydrate, with 14 Ϯ 2% of total energy derived from fructose (PMI Nutrition TestDiet, St. Louis, MO). The balance of metabolizable carbohydrate was in the form of starch. To improve palatability, the diet was supplemented with human food-grade frankfurters (4 -6 daily), for a final diet composition of ϳ19% protein, 60% fat, and 21% carbohydrate, with 11 Ϯ 0.7% of total energy derived from fructose and a total of ϳ2,000 kcal/day. Six dogs (P group) remained on the chow/meat diet throughout pregnancy. The diets for both groups met the nutritional recommendations for pregnant dogs (38) . In addition to the P and P-HFF groups, normal nonpregnant (NP) female dogs (n ϭ 3) underwent only oral glucose tolerance testing (OGTT) and pancreatic islet analyses. The NP dogs underwent the same surgical catheterization procedure as the P and P-HFF dogs and consumed the chow and meat diet fed to the P group, but ultimately they were utilized in other experimental protocols.
Approximately 4 days after the dogs were randomized to their diet groups, they underwent surgery for insertion of sampling catheters in the left femoral artery, hepatic portal vein, left common hepatic vein, and right common iliac vein, as well as splenic and jejunal vein catheters for infusion into the hepatic portal circulation. Ultrasonic flow probes (Transonic Systems, Ithaca, NY) were placed around the hepatic artery, portal vein, and external iliac artery. Two of the P-HFF dogs underwent partial pancreatectomy (removal of ϳ25-40% of organ weight) to simulate an insulin secretion defect. These animals exhibited normal stools with no evidence of fat malabsorption and did not require replacement of pancreatic digestive enzymes after surgery. Subsequently, it became apparent that the partial pancreatectomy was unnecessary to create an impaired insulin secretory response and glucose intolerance, and no additional animals underwent the procedure. Since the dogs with partial pancreatectomy did not differ in response to any of the study procedures from those with normal pancreata, with the exception of their insulin concentrations at 120 min after the oral glucose load (see RESULTS), all of the P-HFF dogs were combined in a single group. However, data are also presented for every parameter for the subset of P-HFF animals (n ϭ 4) with normal pancreata. Recently, we demonstrated in male dogs consuming a diet similar to the HFF diet in this report that partial pancreatectomy did not significantly impact the response to either a hyperinsulinemic euglycemic clamp or a hyperinsulinemic hyperglycemic clamp (17) . Random plasma glucose concentrations were obtained in the P-HFF dogs during the first postsurgical week, and hyperglycemia was not observed. Criteria and preparation for study were as previously described (20) .
Prepregnancy weights in the dogs with partial pancreatectomy (obtained in the breeder's facility) were 22.6 and 18.7 kg; the 4 P-HFF dogs with normal pancreata weighed 20.4 Ϯ 1.7 kg (range 17.0 -23.6 kg) before pregnancy. Prepregnancy weights in the P group were 20.7 Ϯ 0.4 kg, and the weights in the NP dogs were 21.1 Ϯ 1.8 kg. The NP, P, and P-HFF dogs were 11.2 Ϯ 2.1, 12.8 Ϯ 1.2, and 12.2 Ϯ 0.7 mo of age at the time of study, respectively, and the P-HFF dogs with partial pancreatectomy were 11 and 11.5 mo of age at the time of study. All dogs were mixed breed animals with a hound background. Experiments were carried out throughout the year in all groups without regard to season.
Metabolic Characterization
Oral glucose tolerance test. Approximately 10 days after surgery, 3 NP, 4 P and all P-HFF dogs underwent an OGTT following an overnight (18 h) fast. On the morning of the OGTT, a cannula (BD Intracath no. 384906, Sandy, UT) was inserted in a saphenous vein and advanced 20 cm, so that the distal end was in the inferior vena cava, to allow sampling of mixed deep venous blood. After basal sampling for glucose and insulin concentrations, the dogs consumed an oral glucose load (0.9 g/kg) within 2-3 min, and blood samples were collected for 3 h postload.
Hyperinsulinemic euglycemic clamp. Two-step hyperinsulinemic euglycemic (HIE) clamps were performed in the conscious state on all P and P-HFF dogs after an overnight fast in the 7th to 8th week of gestation, 6 to 7 days after the OGTT. At Ϫ130 min, primed ( from 120 to 240 min (high-insulin period). The first step utilized an insulin infusion rate previously demonstrated to suppress endogenous glucose production (EGP) in normal NP dogs Ӎ50%, and the second step used an infusion rate known to suppress EGP fully and increase whole body glucose utilization approximately seven times the basal level in normal NP dogs (21) . Blood samples were collected from the artery and the portal, hepatic, and iliac veins during the last 30 min of each period following techniques previously described (20, 54) . Metabolite and hormone analyses. Analyses have been described in detail previously (20) and included plasma concentrations of glucose, insulin, glucagon, cortisol, nonesterified fatty acids (NEFA), and [ 3 H]glucose and blood concentrations of lactate, alanine, and glycerol.
Pancreatic Islet Analyses
Tissue preparation and histology. Tissue (1-2 g) was taken from the distal end of the splenic lobe of the pancreas of normal P dogs and NP female dogs at the time of laparotomy for vascular catheterization. Pancreata were dissected in cold PBS and fixed immediately in ice-cold 4% paraformaldehyde at 4°C for 3-4 h. The tissues were dehydrated and embedded in paraffin and sectioned at 5 m. Sections were deparaffinized in xylene and rehydrated in a decreasing ethanol series. Pancreata of three nonpregnant and three pregnant animals were used for the analysis.
The primary antibodies used were guinea pig anti-insulin, 1:1,000 dilution(Millipore); guinea pig anti-glucagon, 1:1,000 dilution (Millipore); and rabbit anti-human proliferating cell nuclear antigen (PCNA), 1:100 dilution (Santa Cruz Biotechnology). Detection of PCNA required antigen retrieval and was done in Antigen Retrieval Citra solution (Biogenex) using a preheat steamer for 25 min. Primary antibody incubations were overnight in a humid chamber at 4°C. For immunofluorescence, CY2-conjugated goat anti-guinea pig or CY3-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch) were used as secondary antibodies at a 1:300 dilution. The mounting medium contained 1.5 g/ml nuclear fluorogen 4=,6=-diamidine-2-phenylindole (DAPI; Molecular Probes, Eugene, OR). Horseradish peroxidase (HRP)-conjugated anti-guinea pig IgG, 1:250 dilution (Jackson ImmunoResearch) was used as secondary antibody and diaminobenzidine (DAB) as chromogen for immunohistochemical staining.
Samples were viewed under bright-field illumination with appropriate optical filters (immunofluorescence) using an Olympus BX41 microscope (Tokyo, Japan) and a digital camera with the Magnafire program (Optronics, Chelmsford, MA). TIFF images from each experiment were processed equivalently in Adobe Photoshop.
Average islet size. Pancreata were removed and processed for histology. Six sections 250 m apart were used for the analysis. Total pancreatic area (identified by eosin counterstain) was quantitated using Metamorph software (Molecular Devices, Downing town, PA). After insulin immunolabeling, the sections were scanned using a Nikon Super Coolscan9000. Islets were visualized by the brown DAB precipitate. Total islet area was determined by manual demarcation of the HRP-DAB stained (brown) islets. The islets were sorted into four different groups (5-20, 21-100, 101-300, and Ͼ300 m 2 ) according to their size. The number of islets in each group was counted and compared between pregnant and nonpregnant animals. Average islet area was measured by dividing the total islet area by the total number of islets.
␤-Cell proliferation. Pancreata were removed, processed, and fixed as described above. To assess ␤-cell proliferation, sections were coimmunolabeled for PCNA and insulin. Every insulin-positive cell in one section per slide was examined. Two sections per animal were analyzed.
Calculations
For all calculations, plasma glucose concentrations were converted to blood concentrations as previously described (40) . Total hepatic blood flow was assessed by hepatic extraction of ICG and ultrasonic flow probes (19) . Hepatic balance calculations performed with either type of flow data did not differ significantly. The data reported presently were calculated using ultrasonically-derived flows, because this does not require an assumption about the relative proportion of hepatic flow provided by the hepatic artery vs. the portal vein. Net hepatic substrate balance (NHB) was calculated as LOADout Ϫ LOADin. LOADout ϭ H ϫ FH and LOADin ϭ (FA ϫ A) ϩ (FP ϫ P), where A, P, and H are the arterial, portal vein, and hepatic vein substrate concentrations, respectively, and FA, FP, and FH are the arterial, portal vein, and total hepatic blood or plasma flow, as appropriate for the particular substrate. Hindlimb glucose balance was calculated as the difference between the iliac vein and arterial blood concentrations, multiplied by the iliac blood flow. Glucose turnover was calculated with a two-compartment model (35) using dog parameters (24) . Hepatic sinusoidal insulin concentrations were calculated as LOADin/FH, using arterial and portal vein plasma flows. HIE clamp data related to the liver [e.g., NHB and endogenous glucose production] are expressed per 100 grams of maternal liver, to control for any possible impact of differences in body weight. Total liver weights were 619 Ϯ 70 and 578 Ϯ 38 g in the P and P-HFF groups, respectively (P ϭ 0.6). Expressing the liver data per kilogram of body weight (as was done for glucose infusion rate and other parameters related to whole body glucose disposal) would not have changed any conclusion. Area under the curve (AUC) was calculated using the trapezoidal rule.
Pancreatic tissue data were analyzed by unpaired t-test or two-way ANOVA with Bonferroni's posttests using GraphPad Prism version 5.01. A P value Յ0.05 was considered significant. Statistical comparisons of metabolic data were made using two-way repeatedmeasures ANOVA with post hoc analysis employing Tukey's test. All metabolic data obtained during the HIE clamps are means Ϯ SE of 3 sampling times during the last 30 min of each period.
RESULTS
Oral Glucose Tolerance Test
The peak postload glucose concentrations in the P dogs were no different from those in the NP group, but the P group required more time to return to basal concentrations (Fig. 1) . Thus the AUC of the glucose response, calculated as change from basal concentrations, was 25% greater in the P vs. NP group. The glucose and insulin concentrations in the two P-HFF dogs that underwent partial pancreatectomy did not differ from the mean of those with normal pancreata except for the insulin concentrations at 120 min, and therefore all P-HFF dogs were combined in a single group. The basal glucose concentrations in P-HFF dogs were not significantly different from those in the other two groups, but the P-HFF dogs exhibited postload glucose intolerance (AUC Ͼ3-fold that of the P group). At 1 h, the plasma glucose concentrations were 9.1 Ϯ 0.6, 8.2 Ϯ 0.7, 13.5 Ϯ 1.2, and 13.7 Ϯ 1.8 mM in the NP, P, P-HFF (n ϭ 6), and P-HFF subset with normal pancreata (n ϭ 4) groups, respectively, and at 2 h the glucose concentrations were 6.0 Ϯ 0.7, 7.9 Ϯ 1.0, 10.3 Ϯ 1.3, and 9.0 Ϯ 1.6 mM, respectively [at both time points P Ͻ 0.01 for P-HFF (both the entire group, n ϭ 6, and the subset of n ϭ 4) vs. the NP and P groups]. Plasma insulin concentrations did not differ significantly between P and P-HFF (entire) groups at any time, but both groups had lower insulin concentrations at the 30-and 60-min postload time points than the NP group (Fig.  1 ). Thus the P-HFF group as a whole displayed a remarkable degree of IGT without hyperinsulinemia.
HIE Clamps
Maternal weight, weight gain, and fetal number. Body weights at the time of the HIE clamps were 22.4 Ϯ 1.5, 23.4 Ϯ 1.0 2, and 23.0 Ϯ 1.2 kg in the P, P-HFF, and P-HFF subset with normal pancreata, respectively (P ϭ 0.5). Weight gain between the time of surgery and the HIE clamp averaged 2.1 Ϯ 0.9, 2.7 Ϯ 0.3, and 2.8 Ϯ 0.4 kg in the P and P-HFF groups and the P-HFF subset with normal pancreata, respectively (P ϭ 0.3). The animals in the P and P-HFF groups had 7.8 Ϯ 0.6 and 8.2 Ϯ 0.7 fetuses, respectively (P ϭ 0.7), and the P-HFF subset (n ϭ 4) had 8.3 Ϯ 1.0 fetuses.
Plasma hormone concentrations and hepatic blood flow. Total hepatic blood flow did not differ significantly between groups, and it was stable over time within each group (Table 1) . Arterial and hepatic sinusoidal plasma insulin concentrations did not differ significantly between groups at any time during the basal and clamp periods (Table 1) . Arterial insulin concentrations increased 6 -12 pmol/l over the basal level during the low-insulin period and then increased an additional 5.5-fold during high insulin. Glucagon and cortisol remained at their basal concentrations in both groups throughout the experiments (Table 1) . Thus, as designed, the plasma hormone concentrations were fixed at the same levels in the groups. The use of somatostatin and replacement of insulin and glucagon at the same levels helped to ensure that there would be no systematic differences in the responses of the dogs with partial pancreatectomy vs. those with normal pancreata in the P-HFF group.
Glucose metabolism. The dogs in both groups remained euglycemic throughout the basal and experimental periods, and the glucose concentrations did not differ significantly between groups at any time ( Fig. 2A) . Net hepatic glucose output (NHGO) in the basal state tended to be greater (25%) in the P vs. the P-HFF group, but this did not reach statistical significance (P ϭ 0.2). During low insulin, NHGO declined from the basal level by 56 and 48% in the P and P-HFF groups, respectively (P ϭ 0.2), such that the rates during low insulin were virtually identical. During high insulin, however, the P group switched from NHGO to a low rate of net hepatic glucose uptake (NHGU: Ϫ5.6 Ϯ 6.1 mol·100 g liver Ϫ1 ·min Ϫ1 ). The P-HFF group did not exhibit NGHU but maintained a low rate of NHGO (7.8 Ϯ 2.8 mol·100 g liver Ϫ1 ·min Ϫ1 , P Ͻ 0.05 between groups). The change over time in net hepatic glucose balance (i.e., the rate during the basal period minus that in the high insulin period) in the P-HFF group was only 57% of that in the P group (P Ͻ 0.05, Fig. 2B ). EGP was not statistically different between groups in the basal period (17% less in P-HFF than P; P ϭ 0.25) or at any other time during the clamp studies ( Table 2 ). The percent change from basal level in EGP did not differ between groups at either insulin infusion rate (44 Ϯ 16 vs. 42 Ϯ 10% during low insulin and 62 Ϯ 19 vs. 63 Ϯ 14% during high insulin in the P and P-HFF groups, respectively).
During high insulin, hindlimb glucose uptake increased 72% in the P group, compared with basal level, but it increased only 27% in the P-HFF group (P Ͻ 0.05 between groups; Fig. 2C ). The rate of nonhepatic glucose uptake was very similar between groups during the basal and low-insulin periods, but it tended to be reduced (P ϭ 0.11) in the P-HFF vs. P group in response to high insulin (25.5 Ϯ 1.7 vs. 32.8 Ϯ 5.6 mol·kg Ϫ1 ·min Ϫ1 ; Fig. 2D ). In addition, the rate of glucose disappearance (R d ) was significantly greater in the P than P-HFF group during the high-insulin period ( Table 2) . The glucose infusion rates (GIRs) required to maintain euglycemia during low and high insulin, respectively, were 11.7 Ϯ 1.7 and 33.9 Ϯ 5.6 mol·kg Ϫ1 ·min Ϫ1 in the P group and 11.7 Ϯ 0.6 and 23.9 Ϯ 1.7 in the P-HFF group (P Ͻ 0.05 between groups during high insulin; Fig. 2E ).
During the HIE clamps, there were no apparent differences between the P-HFF dogs that underwent partial pancreatectomy and those with normal pancreata. GIRs during low insulin were 12.1 and 13.9 mol·kg Ϫ1 ·min Ϫ1 in the dogs with partial pancreatectomy, and they ranged from 10.6 to 11.6 mol·kg Ϫ1 ·min Ϫ1 in the P-HFF dogs with normal pancreata. Data are means Ϯ SE for 3 sampling times in the last 30 min of each period. P, normal pregnant dogs (n ϭ 6); P-HFF, pregnant dogs consuming high-fat/ high-fructose diet (n ϭ 4 indicates dogs with normal pancreata; n ϭ 6 indicates the combined group containing the 4 dogs with normal pancreata and 2 with partial pancreatectomy). There were no significant differences between P and P-HFF dogs and no differences between the entire P-HFF group and the subset with normal pancreata. None of the parameters other than insulin changed significantly from the basal period during the insulin infusion periods.
During high insulin, the GIRs in the animals with partial pancreatectomy were 26.2 and 20.6 mol·kg Ϫ1 ·min Ϫ1 , and those in the other P-HFF dogs were 20.6 to 28.9 mol·kg Ϫ1 ·min Ϫ1 . Other indexes of hepatic and whole body glucose metabolism were also very similar in the dogs with partial pancreatectomy vs. those with normal pancreata. Thus all animals receiving the HFF diet were combined in a single group. In summary, the P-HFF dogs displayed greater insulin resistance than the normal P dogs, reflecting loss of skeletal muscle insulin sensitivity as well as an apparent mild impairment of liver insulin sensitivity. The subgroup of four P-HFF dogs with intact pancreata was not different in any detectable way from the entire P-HFF group, although the small group size reduced statistical power.
NEFA, glycerol, ␤-hydroxybutyrate, and lactate. Arterial plasma NEFA and blood glycerol and ␤-hydroxybutyrate concentrations were not different between groups at any time (Table 3) ; they declined significantly from the basal level during low insulin and/or high insulin infusion in both the P and P-HFF groups. Net hepatic NEFA and glycerol uptake and ␤-hydroxybutyrate output declined in parallel with their concentrations and did not differ significantly between groups, although there was a tendency for the rates to be higher in the P-HFF group than in the P group. However, net hepatic fractional extraction of NEFA increased in the P-HFF but not in the P group during high insulin (P Ͻ 0.05 between groups).
Arterial blood lactate concentrations were similar in the two groups throughout the clamp studies (Table 3 ). Both groups exhibited net hepatic lactate uptake throughout all study periods. The rates were similar in the two groups during the basal period, but the rate fell approximately one-third during hyperinsulinemia in the P group and tended to rise in the P-HFF group. Thus the rate of net hepatic lactate uptake was significantly greater in the P-HFF than in the P group during both the low-and high-insulin periods. Thus it appeared that the livers of the P-HFF dogs, which took up less glucose than those of the P dogs during the high-insulin period, instead removed more gluconeogenic precursors from the circulation.
Maternal Islet Morphology
The blunted insulin response in the P and P-HFF groups during the OGTTs raised questions about the extent and type of pancreatic adaptation during pregnancy in the dog. Therefore, pancreatic tissue was collected from P dogs not receiving the HFF diet and from normal NP female dogs at the time of laparotomy. 2 . Euglycemic hyperinsulinemic clamp data in P group (n ϭ 6, open bars), P-HFF combined group (n ϭ 6, filled bars), and P-HFF subset with normal pancreata (n ϭ 4, hatched bars): arterial plasma glucose concentrations (A), net hepatic glucose balance (B), hindlimb glucose uptake (C), nonhepatic glucose uptake (D), and glucose infusion rate (E). *P Ͻ 0.05 vs. P group.
The majority of islets were 5-20 or 21-100 m 2 in both the pregnant and nonpregnant animals, with no differences observed between groups (Fig. 3A) . Within the four size categories, the mean islet size was remarkably similar between nonpregnant and pregnant groups (Fig. 3B) . The average islet area did not differ significantly between groups (Fig. 3C) . Proliferating cells were observed in the exocrine tissue but rarely in the islets of the PCNA/insulin-stained (pancreatic) sections. There was no evidence of an adaptive response of the islets to normal pregnancy.
DISCUSSION
Healthy pregnant women exhibit a 33-78% loss of whole body insulin sensitivity by late pregnancy (32), and we previously reported similar findings in the normal pregnant dog during the 3rd trimester (43% reduction in insulin sensitivity compared with nonpregnant female dogs) (21) . In humans, obesity and GDM are associated with a further reduction in insulin sensitivity compared with the normal pregnant state (11, 13, 50) . Consistent with this, the P-HFF group in the current study exhibited a 20 -30% reduction in whole body insulin sensitivity (based on GIR and glucose R d ) in the high-insulin period compared with the P group. The HIE clamp technique has been assumed to reflect primarily muscle glucose disposal (29) , and in keeping with this, the nonhepatic and hindlimb glucose uptakes in the P-HFF group were reduced ϳ22 and 30%, respectively, compared with rates in the P group. The hindlimb of the dog is 66% skeletal muscle by weight, with most of the remainder being composed of bone (54) , and thus provides an index of skeletal muscle glucose uptake.
Despite the importance of the muscle in glucose disposition during hyperinsulinemia, the liver's response is also of relevance. In normal late pregnancy, the liver retains much of its sensitivity to insulin (14, 21, 22, 26) . However, in pregnancy complicated by diabetes, hepatic insulin sensitivity is likely to be impaired (32) . Obese women with GDM were shown to have an impaired suppression of EGP (ϳ10% less than obese nondiabetic pregnant women) during the 3rd trimester (11). This effect was evident at an insulin infusion rate of 40 mU·m 2 ·min Ϫ1 , but not at 20 mU·m 2 ·min Ϫ1 (11), which is in general agreement with the current data. At the lower step of the two-step HIE clamp, arterial plasma insulin concentrations increased only 6 -12 pM in both the P and P-HFF groups. This subtle increase in insulin was sufficient to decrease NHGO by Ն48% and EGP Ͼ 40% in both groups. The normal liver is exquisitely sensitive to insulin such that, in both the human and the dog, hepatic glucose production is ϳ65% inhibited with basal insulinemia (16) . During the low-insulin period, the P and P-HFF groups had virtually identical rates of NHGO and EGP, although there was a tendency for suppression of both parameters (compared with the basal state) to be reduced in the P-HFF group. However, in response to high insulin, the P dogs shifted to a low rate of NHGU, whereas the P-HFF dogs remained in a state of NHGO (P Ͻ 0.05 between groups), with a significantly greater change from the basal rate in P than in P-HFF dogs, thus revealing a defect in hepatic insulin sensitivity. NHGO is the net result of two processes, hepatic glucose output and uptake. Interestingly, there was no significant difference in suppression of EGP between the P and P-HFF groups, suggesting that it was the effect of insulin on hepatic HGU that was most blunted in the P-HFF group. The euglycemic conditions of the current investigation are not ideal for the examination of this question, and therefore further studies are underway to assess the response of P and P-HFF dogs to hyperinsulinemia and hyperglycemia under conditions mimicking the postprandial state. HGU cannot be assessed in the human because of the invasive catheterization required, and there have been no reports of measurement of HGU in a rodent model, reflecting the difficulty of catheterizing the hepatic vein in the rat or mouse. The dog remains one of the very few models in which it is possible to assess HGU quantitatively. Impaired HGU contributes to postprandial hyperglycemia. It is a determinant of HbA 1c concentrations (55) and is thus linked to adverse effects in both the pregnant woman and her offspring (12, 27, 47) . Thus the canine model will allow us to address important questions about regulation of HGU in pregnancy that cannot be answered in humans. In addition, the dog has an advantage over both humans and rodent models in insulin clamp experiments: in the dog, insulin can be replaced into the hepatic portal vein, the normal route for its secretion and delivery to the liver. Consequently, the physiological arterial-portal insulin gradient can be maintained, with insulin concentrations in the portal vein approximately three times those in the peripheral circulation. The gastrointestinal tract extracts approximately one-third of the insulin to which it is exposed, and therefore when insulin is infused via peripheral vein, the portal vein concentration is always lower than that in the general circulation. This means that during basal and low-rate insulin infusions [when insulin data in the rodent are reported as "basal" (e.g., Ref. 33) ], the arterial concentrations are maintained near basal, but those in the portal vein are actually significantly lower than basal, resulting in underinsulinization of the liver. Underinsulinization frees the liver to respond to a variety of signals of unknown physiological significance (e.g., Refs. 33, 53). During higher rate peripheral venous infusions, the liver is adequately insulinized, but the adipose tissue and muscle are relatively overinsulinized. As a result of the indirect effects of NEFA on hepatic glucose production (49) , overinsulinization of peripheral tissues also impacts the liver. Thus only with portal vein hormone replacement can hepatic glucose metabolism be examined in a physiological context.
If the standards for interpreting OGTT in pregnant women (2) are applied to the canine data, it is clear that fasting blood glucose Ͼ5.3 mM is not a sensitive indicator of the presence of diabetes in the dog, because all of the NP dogs and threequarters of the P dogs had fasting concentrations above this level. Nevertheless, none of the NP dogs had glucose concentrations exceeding the cutoff for gestational diabetes at any time after glucose ingestion, and only one P dog had a single postload glucose concentration that exceeded the diagnostic criteria; that animal had a fasting glucose concentration Ͻ5.3 mg/dl but a 120-min postload glucose concentration of 10.3 mM. If the fasting blood glucose were eliminated from consideration, then four of the P-HFF dogs would have met the criteria for diagnosis of GDM, and the other two would have been considered to have IGT (defined as 1 abnormal result on the OGTT). There is no sharp cutoff in risk associated with altered glycemic regulation in pregnancy; instead, the responses to antepartal glucose testing appear to fall on a continuum in their association with maternal and fetal risk (27, 44, 45, 47) . IGT during pregnancy has been found to be a predictor of adverse fetal outcomes (1, 27, 39) , as well as increased likelihood of later development of metabolic syndrome, prediabetes, and type 2 diabetes in the mother (44 -46) . The P-HFF dog thus provides a relevant model of the continuum of abnormal metabolic response during pregnancy. The mongrel dog, like the human, reflects a varied genetic background. Although this can lead to greater variance in insulin and glucose responses, it also makes the dog a more robust model of human physiology and pathophysiology than small animal models described to date, where findings are highly strain dependent (3, 5, 36) .
The P-HFF dog does not exhibit hyperinsulinemia as in human GDM or rodent models of GDM. In most species maternal islets undergo adaptive changes to meet the metabolic demands of pregnancy. One of the characteristic changes is an increase in ␤-cell mass. An increase in cell size (hypertrophy), cell number (hyperplasia), or differentiation of new ␤-cells from the progenitors (neogenesis) could potentially contribute to increased ␤-cell mass under different stimulating conditions (7, 8, 37, 42, 56) . Maternal ␤-cell mass expansion in rodents is mainly accomplished by proliferation (30, 41, 58) . Studies using human autopsy samples revealed islet enlargement and ␤-cell hyperplasia during pregnancy (52) . A detailed analysis of islet changes in large animals during pregnancy has never been reported. We performed morphometric analyses in dog pancreas at 5-6 wk of pregnancy to assess the following parameters: islet size, islet number, and ␤-cell proliferation. None of these parameters differed significantly between nonpregnant and pregnant dogs. Despite the presence of marked hyperglycemia during the OGTT in P-HFF vs. P dogs, insulin concentrations in the P-HFF dogs did not increase more than those in the P dogs, and both groups had lower 30-and 60-min postload insulin concentrations than the NP dogs. These findings are consistent with the lack of ␤-cell adaptation to pregnancy observed in the dog. We have demonstrated that the FoxM1 transcription factor is a key regulator of ␤-cell proliferation in pregnancy in mice (58) . In the mouse, FoxM1 expression in pancreatic islets is increased Ͼ50% over nonpregnant levels by gestational day (GD) 14.5, and expression returns to basal levels within 8 days postpartum, reflecting the changes in ␤-cell mass. Pancreas-specific deletion of FoxM1 (FoxM1 ⌬panc ) significantly reduces ␤-cell proliferation and pancreatic insulin content, and FoxM1 ⌬panc mice develop GDM by GD 15.5 (58) . FoxM1 is a downstream effector of placental lactogen signaling (53) . In light of our current findings suggesting a lack of ␤-cell compensation during canine pregnancy, it is perhaps worth noting that the dog, unlike many mammalian species, lacks placental lactogen (18, 25) . The response of the P-HFF group to the OGTT strongly suggests an alteration in ␤-cell function analogous to the ␤-cell defect that contributes to human GDM and IGT.
Of all the pregnant animals that underwent the OGTTs, only the P-HFF dogs with partial pancreatectomy exhibited hyperinsulinemia, and they did so only at the 2-h time point (127 and 209 vs. 45 Ϯ 16 pM in the remainder of the P-HFF dogs). The fact that the dogs with partial pancreatectomy remained markedly hyperglycemic even though hyperinsulinemic suggests a reduction in insulin sensitivity and/or glucose effectiveness in those dogs. However, there were no detectable differences between those dogs and the other P-HFF animals during the HIE clamps, which reinforces the need for studies in the presence of hyperglycemia to fully define defects in glucose metabolism.
The nonpregnant dog absorbs food slowly, requiring ϳ18 h to complete the absorption of the normal chow and meat meal (23) , and the pregnant dog requires at least as long, if not longer, to complete the process (Moore MC, unpublished observations). Postprandial arterial glucose levels in the nonpregnant dog fed a meat and chow meal are elevated only minimally, rising from a basal concentration of 5.6 mM to a peak of 6.1 mM 4 h after the meal (23), a finding that is likely at least partially attributable to the slow rate of absorption. When continuous 36-h transcutaneous monitoring of glucose concentrations was carried out in a single pregnant dog (8th week of gestation) receiving the meat and chow diet, the recorded glucose concentrations never exceeded 6.7 mM (Moore MC, unpublished observations). In the pregnant dog, the products of conception constitute a significant portion of the total maternal body mass by late pregnancy, and they play a substantial role in non-insulin-mediated (at least in regard to maternal insulin) glucose disposal. Thus the lack of islet adaptation might reflect the fact that there is little stimulus for adaptation under normal circumstances. Even in the insulinresistant P-HFF dogs, only a challenge such as the OGTT elicited sufficient hyperglycemia to unmask any evidence of a ␤-cell defect.
Arterial blood glycerol decreased from basal in the P group even at the low-insulin infusion rate, and it fell significantly in both groups during the high-insulin infusion. Since glycerol is a sensitive index of lipolysis, it appears that peripheral lipid metabolism in the P-HFF dogs remains sensitive to the higher rate of insulin infusion. Similarly, ␤-hydroxybutyrate concentrations and net hepatic output declined in the P group during low insulin, but a fall was evident in the P-HFF group only during the high-insulin period. On the other hand, net hepatic alanine and lactate uptake rates were greater in the P-HFF group than in the P group during high-insulin infusion, which likely reflects heavier reliance of the P-HFF group on gluconeogenic substrates to maintain hepatic glucose production. Consistent with this, net fractional extraction of NEFA increased in the P-HFF but not in the P group. NEFA increase the rate of gluconeogenesis by both providing fuel for the process and stimulating the activity of fructose-1,6-bisphosphatase (6, 43, 51) .
In summary, the dog fed a high-fat/high-fructose diet in the last half of pregnancy displays a deterioration of glucose tolerance and a greater impairment of whole body and hepatic insulin sensitivity compared with the normal pregnant animal, similar to the findings in humans with GDM (13, 50) . This effect is evident even in the absence of overt obesity. The lack of compensatory ␤-cell proliferation or hyperplasia in the pregnant dog likely contributes to the altered glucose tolerance and to the lack of hyperinsulinemia in the model. Thus, as in the human with GDM, the P-HFF dog exhibits a ␤-cell defect. The dog fed a high-fat/high-fructose diet provides a useful large animal model for assessment of pathophysiology and interventions for IGT and GDM.
